Public health, access to healthcare services, and food and nutrition are some of the most important issues facing people ...

Yuvanci (single tablet combination therapy [STCT] of macitentan and tadalafi) has been approved by the European Commission ...

Johnson & Johnson (J&J) and Legend Biotech have shared positive long-term results for their BCMA-directed T-cell ...

Effective brand strategies are like a well-made jigsaw but they can end up looking nothing like the picture that was agreed ...

Many initiatives have tried to address this partnership challenge: the Healthcare Communications Association’s (HCA) own ...

This Blood Cancer Awareness Month, we want to highlight the critical role of patient-centricity in building awareness, ...

Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and adaptability critical for success. Our worldwide team of 190,000 ...

Eli Lilly has announced that it is investing $4.5bn into a new US facility for advanced manufacturing and drug development. The Lilly Medicine Foundry will give the company the ability to research new ...

Research on the state of the customer experience (CX) that the global pharmaceutical industry provides to healthcare professionals (HCPs) has been released by DT Consulting, an Indegene company. For ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) as an add-on maintenance treatment for chronic obstructive pulmonary disease (COPD). The ...

NHS England has announced that hundreds of babies have begun to be tested for over 200 genetic conditions as part of a study led by Genomics England. The Generation Study is evaluating the potential ...

The US Food and Drug Administration (FDA) has granted rare paediatric disease (RPD) designation to Enterprise Therapeutics’ investigational cystic fibrosis therapy. Estimated to affect more than ...